Latest Commercial Sales News

Page 2 of 9
EVE Health Group has begun commercial sales of Libbo, an oral dissolving film for erectile dysfunction, supported by a new digital men’s health platform. The company also expanded its pharmaceutical pipeline and secured $1.3 million in fresh capital to fund ongoing development and commercialization.
Ada Torres
Ada Torres
29 Apr 2026
LTR Pharma has wrapped up recruitment for its SPONTAN Phase II pharmacokinetic study, with interim results expected soon to bolster FDA approval efforts. Meanwhile, US commercial talks for ROXUS advance cautiously under the FDA 503(a) personalised medicine pathway.
Ada Torres
Ada Torres
28 Apr 2026
Volt Group’s first quarter of FY26 saw ordinary revenue receipts surge 150% year-on-year to $3 million, driven by the integration of 4D Delta and strong contributions from its subsidiaries Wescone and EcoQuip.
Victor Sage
Victor Sage
24 Apr 2026
Green360 Technologies has produced its first commercial batch of Eco-Clay under a tolling deal with Calix, advancing its low-carbon cement alternative towards market entry in Victoria by mid-2026.
Maxwell Dee
Maxwell Dee
20 Apr 2026
Memphasys Limited has marked a milestone quarter with revenue surpassing A$100,000, driven by repeat orders and multi-year contracts, signalling its transition to a commercially focused biotech business.
Ada Torres
Ada Torres
17 Apr 2026
Aguia Resources’ Brazilian subsidiary has achieved a key regulatory milestone with official fertiliser registration, enabling commercial sales of its PAMPAFOS phosphate product in Brazil’s large agricultural market.
Maxwell Dee
Maxwell Dee
8 Apr 2026
Syrah Resources has opened its retail entitlement offer to raise approximately A$104 million, supported by strategic funding proposals from US and Australian government-linked entities. The capital raise aims to underpin the ramp-up of its Balama graphite mine and Vidalia anode material facility.
Maxwell Dee
Maxwell Dee
2 Apr 2026
GCM Corporation has launched its first Very High Density (VHD) heat sink product line, marking a pivotal step from development to commercial sales in thermal management technology.
Sophie Babbage
Sophie Babbage
1 Apr 2026
Firebrick Pharma has secured its first regulatory approval for Nasodine Nasal Spray in Indonesia, paving the way for entry into Southeast Asia’s largest market. This milestone marks a significant step in the company’s international expansion strategy.
Ada Torres
Ada Torres
27 Mar 2026
Green360 Technologies has inked a binding toll treatment agreement with Calix Limited to commercially produce Eco-Clay, a low-carbon cement replacement, marking a key step toward scaling sustainable concrete solutions in Australia.
Maxwell Dee
Maxwell Dee
23 Mar 2026
Rhythm Biosciences has completed the first commercial sale of its ColoSTAT® blood test for colorectal cancer, confirming the full clinical and logistical process is operational and ready for expansion.
Ada Torres
Ada Torres
11 Mar 2026
Avecho Biotechnology has completed recruitment for the interim analysis cohort of its pivotal Phase III trial for a CBD insomnia treatment, with results expected in June 2026. This milestone could significantly de-risk the program and unlock major market opportunities.
Ada Torres
Ada Torres
2 Mar 2026